Navigation Links
New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
Date:8/31/2007

CAIRNS, Australia, Aug. 31 /PRNewswire/ --

What and When

Data from a six-month study of ramelteon will be presented in poster format at worldsleep07: The 5th World Congress of the World Federation of Sleep Research and Sleep Medicine Societies to be held in Cairns, Australia September 2-6, 2007. This large clinical study demonstrated that ramelteon was effective in reducing time to fall asleep for up to six months versus placebo in adult patients with chronic insomnia.

A total of 451 patients age 18 or older with chronic insomnia were randomized in this clinical study. Patients were given a nighttime dose of ramelteon 8 mg or placebo for up to 24 consecutive weeks with assessments performed after week one and months one, three, five and six of treatment.

Study results revealed consistent and statistically significant improvements in time to sleep onset using objective assessment via polysomnography -- a test that records brain activity and other body functions during sleep. Long-term use of ramelteon 8 mg was well tolerated and showed no evidence of next-day residual effects, pharmacological tolerance, rebound insomnia or withdrawal symptoms.

Poster 525 will be presented on Monday, September 3, 4:00 - 6:00 p.m.

Australian Eastern Standard Time To arrange an interview with Steven Sainati, please contact Amy Losak at

646-935-3917

Ramelteon is marketed by Takeda Pharmaceuticals North America, Inc. in the United States as ROZEREM(TM)(ramelteon).

About ROZEREM

ROZEREM(TM) (ramelteon) is indicated for the treatment of insomnia characterized by difficulty with sleep onset. ROZEREM can be prescribed for long-term use. ROZEREM is the first and only prescription sleep medication that has shown no evidence of abuse or dependence in clinical studies,* and has not been designated as a controlled substance. With the exception of ROZEREM, all other prescription me
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...Nov. 9 ARmark Authentication Techn...n alliance in the development and introduction of ...on technology that incorporates microscopic covert...gs of solid oral dosage forms (SODFs) to prevent c...usive rights to market ARmark,s micro-tags for tab...
(Date:11/9/2009)...PRNewswire-FirstCall/ -- PAREXEL International Cor...rmaceutical services provider, today announced tha...for early phase clinical development through an al...ctures and distributes electrocardiogram (ECG) dev...using Mortara Instrument,s Surveyor Telemetry Cent...
(Date:11/7/2009)...., Nov. 7 Patients reported C1-est...ve therapy in treating acute swelling attacks at a...ic disorder, according to data presented today at ... Immunology (ACAAI) Annual Meeting. The results co...ed in parallel with the ongoing, prospective, open...
Breaking Medicine Technology:ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 2ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 3PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 2PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 3PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 4PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 5Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Nostrils alternate to process competing odors 9636 1Nostrils alternate to process competing odors 9636 2Ochsner and Rouses Markets Partner for Choose Healthy Initiative 54965 1Ochsner and Rouses Markets Partner for Choose Healthy Initiative 54965 2Ochsner and Rouses Markets Partner for Choose Healthy Initiative 54965 3Lost Hikers Backpackers Really Do Walk in Circles 54961 1Lost Hikers Backpackers Really Do Walk in Circles 54961 2Lost Hikers Backpackers Really Do Walk in Circles 54961 3
...r Greater Amounts of the Natural Compound Responsi...ion Benefits, CARVER, Mass., Dec. 13 Decas Cranb... new research showing that 1 oz. (or a 1/4,cup) of...e the,proanthocyanidin (PAC) level of an 8-ounce g... in cranberries, proanthocyanidins (PACs) are,natu...
...Dec. 13 The most recent study from the,landmark F...ance of knowing,the number of LDL particles (LDL-P... heart disease. This longitudinal outcomes study s...ed with fewer cardiovascular disease,(CVD) related...terol. The,findings confirm that low levels of LDL...
Other Medicine Technology:Research Shows Decas Sweetened Dried Cranberries Pack Twice the Proanthocyanidin Punch as Cranberry Juice Cocktail 2Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1) 2
(Date:11/9/2009)... Course, to be Offered in April 2010, Provides Fir... Cambridge, MA (Vocus) November 9, 2... Rights (PHR) first inspected a suspected mass gr...he would need a team of experts to help interpret ...rly was a key first step in securing evidence of a...
(Date:11/9/2009)...hensive Cancer Network (NCCN) has posted a draft w... paradigm for near-term comparative effectiveness ... document introduces the NCCN Comparative Therapeu...t compares the risk-versus-benefit of different tr...ractice Guidelines in Oncology(TM). The paper will...
(Date:11/9/2009).... 9 Health Connect Partners, Inc.,... their inaugural Hospital O.R. and Surgery Center ...Renaissance Hotel in Nashville, Tenn. ,, Health...tal operating room directors and managers from som...he country. Some of the confirmed providers includ...
(Date:11/9/2009)...Newswire/ -- Highlighting a commitment to providin...entertainment and digital display technology optio...erm Care and Hospital Grade LCD HDTVs this week at...ng 2009 annual meeting and exposition (booth #1760... "HealthView(TM)" Long-Term Care LCD HDTVs bring a...
(Date:11/9/2009)...RNewswire-FirstCall/ -- The award-winning document...ion debut on the Sundance Channel on World Diabete...irected by Academy Award® nominee Edward Lach...h type 1 diabetes amid the verdant mountains and s...countries. The children are supported with life-sa...
Breaking Medicine News(10 mins):Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 2Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 3Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 4Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 5Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 6
...niel A. Pelak Join Board of Directors in Preparati...ally Invasive Spinal Treatment ...ertos Medical, Inc., a,privately held medical devi...orbett as its President and Chief Executive,Office...
... to match structural, mechanical properties of hea... 7 (HealthDay News) -- A biological scaffold that ...sed to engineer other tissues has been developed b...t cells or stem cells in order to treat congenital...
... ON Although infection control has been substanti...S crisis of 2003, the number of resistant bacteria..., a new Queen,s University study shows. , Led by ...SARS (Severe Acute Respiratory Syndrome). , The ...
...J., Nov. 7 Schering-Plough,Corporation (NYSE: SG...ysts,and portfolio managers being held on Monday, ...man and CEO, Tom Koestler, Ph.D., executive vice,p...is to provide an update on the company,s late-stag...
...crease risk 8-fold, researchers say , , FR...oking and being obese is not healthy for you, but ...highest among obese smokers. , "We know that obesi...te on Aging. "We found that smoking and obesity ar...
...to Rico, Nov. 7 Triple-S,Management Corporation (...mas, President and Chief Executive Officer, and Ju...resent to investors and financial,analysts at the ...the Internet. You may access the presentation,thro...
Other Medicine News:Health News:Vertos Medical, Inc. Appoints James M. Corbett Chief Executive Officer 2Health News:Vertos Medical, Inc. Appoints James M. Corbett Chief Executive Officer 3Health News:'Scaffold' Could One Day Repair Damaged Hearts 2Health News:'Superbugs' on the rise in Canadian hospitals, new Queen's study shows 2Health News:Smoking Coupled With Obesity Raises Death Risk 2Health News:Smoking Coupled With Obesity Raises Death Risk 3Health News:Triple-S Management Corporation to Present at Credit Suisse 2008 Healthcare Conference 2
...mbination of a screw and a barbed pin. This implan...s for a hammertoe fixation and prevents pistoning ...! Drill and tap the proximal phalanx. Drill the mi...mplant proximally. Press fit the barbed portion of...
Shoulder Instrumentation System
...for excising soft tissue more efficiently than a p...ted edge on the straight scissor helps to maintain...for more efficient resection.,The curved scissors...the perfect tools for ACL stump removal, meniscect...
...for excising soft tissue more efficiently than a p...ted edge on the straight scissor helps to maintain...for more efficient resection.,The curved scissors...the perfect tools for ACL stump removal, meniscect...
Medicine Products: